| [ Print ] | [ Close ] |
| Birth After Caesarean - Planned vaginal birth or planned caesarean section for women at term with a single previous caesarean birth | |
| ISRCTN | ISRCTN53974531 |
| ClinicalTrials.gov identifier | |
| Public title | Birth After Caesarean - Planned vaginal birth or planned caesarean section for women at term with a single previous caesarean birth |
| Scientific title | |
| Acronym | BAC |
| Serial number at source | N/A |
| Study hypothesis |
For women who meet eligibility criteria for a planned VBAC there is no difference in the risk of death or serious adverse outcome for the infant in women who have a planned VBAC compared with planned elective repeat caesarean.
As of 02/02/2012, target number of participants updated from 2180 (including patient preference and RCT arms) to 2314 (including patient preference and RCT arms and allowing for a small 1% loss to follow-up). |
| Lay summary | Not provided at time of registration |
| Ethics approval | Not provided at time of registration |
| Study design | Randomised controlled trial |
| Countries of recruitment | Australia |
| Disease/condition/study domain | Birth after previous caesarean |
| Participants - inclusion criteria | Women with a single prior caesarean presenting in their next pregnancy with a single live fetus in cephalic presentation who have reached 37 weeks gestation, and who don't have a contraindication to a planned VBAC. |
| Participants - exclusion criteria | Women with more than 1 prior caesarean; vertical inverted T or unknown uterine incision; previous uterine rupture; previous uterine surgery (hysterotomy) or myomectomy with entry into uterine cavity; previous uterine perforation; multiple pregnancy; any contraindication to vaginal birth; cephalo-pelvic disproportion; lethal congenital anomaly; fetal anomaly associated with mechanical difficulties at delivery. |
| Anticipated start date | 28/03/2003 |
| Anticipated end date | 07/01/2008 |
| Status of trial | Completed |
| Patient information material | Not available in web format, please use the contact details below to request a patient information sheet |
| Target number of participants | 2314 (including patient preference and RCT arms and allowing for a small 1% loss to follow-up) |
| Interventions | Eligible women will be randomised to either planned vaginal birth after caesarean or planned elective repeat caesarean section or can be entered into their preferred treatment group (patient preference study) |
| Primary outcome measure(s) |
1. Neonatal lung disease
2. Serious neonatal mobidity 3. Perinatal/neonatal mortality |
| Secondary outcome measure(s) |
Secondary outcome(s) for funded study as of 2005:
1. Serious adverse outcomes for the women (up to time of primary hospital discharge) Secondary outcomes for pre-funding draft protocol: 1. Serious adverse outcomes for the women 2. Maternal physical wellbeing 3. Maternal emotional wellbeing 4. Costs of health care for the infant |
| Sources of funding | Australian National Health and Medical Research Council (NHMRC) |
| Trial website | |
| Publications | Protocol on http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17697343 |
| Contact name | Prof Caroline Crowther |
| Address |
University of Adelaide
Women's & Children's Hospital 72 King William Road |
| City/town | North Adelaide |
| Zip/Postcode | 5006 |
| Country | Australia |
| Tel | +61 (0)8 8161 7647 |
| Fax | +61 (0)8 8161 7652 |
| caroline.crowther@adelaide.edu.au | |
| Sponsor | The University of Adelaide (Australia) |
| Address | North Terrace |
| City/town | Adelaide |
| Zip/Postcode | 5005 |
| Country | Australia |
| Tel | +61 (0)8 8161 7647 |
| Fax | +61 (0)8 8161 7652 |
| caroline.crowther@adelaide.edu.au | |
| Sponsor website | http://www.adelaide.edu.au/ |
| Date applied | 06/09/2005 |
| Last edited | 07/02/2012 |
| Date ISRCTN assigned | 05/10/2005 |